Medline, Inc. Class A (MDLN)
NASDAQ:MDLN
Want to see MDLN full AI Analyst Report?
Total Valuation
Medline has a market cap or net worth of $47.62B. The enterprise value is $41.71B.
Market Cap$47.62B
Enterprise Value$41.71B
Share Statistics
Medline has 845,606,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding845,606,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medline’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.69%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.69%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee661.21K
Profits Per Employee26.95K
Employee Count43,000
Asset Turnover0.74
Inventory Turnover4.39
Valuation Ratios
The current PE Ratio of Medline is 70.6. Medline’s PEG ratio is -4.97.
PE Ratio70.6
PS Ratio1.20
PB Ratio3.18
Price to Fair Value3.18
Price to FCF19.56
Price to Operating Cash Flow19.99
PEG Ratio-4.97
Income Statement
In the last 12 months, Medline had revenue of 28.43B and earned 1.16B in profits. Earnings per share was 1.43.
Revenue28.43B
Gross Profit7.52B
Operating Income2.21B
Pretax Income1.25B
Net Income1.16B
EBITDA2.92B
Earnings Per Share (EPS)1.43
Cash Flow
In the last 12 months, operating cash flow was 1.52B and capital expenditures 5.00M, giving a free cash flow of 1.52B billion.
Operating Cash Flow1.52B
Free Cash Flow1.52B
Free Cash Flow per Share1.80
Dividends & Yields
Medline pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change-9.51%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)6.39M
Important Dates
Medline upcoming earnings date is Mar 3, 2027, Before Open (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Medline as a current ratio of 4.29, with Debt / Equity ratio of 111.53%
Current Ratio4.29
Quick Ratio2.37
Debt to Market Cap0.37
Net Debt to EBITDA3.64
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medline has paid 91.00M in taxes.
Income Tax91.00M
Effective Tax Rate0.07
Enterprise Valuation
Medline EV to EBITDA ratio is 15.34, with an EV/FCF ratio of 25.65.
EV to Sales1.57
EV to EBITDA15.34
EV to Free Cash Flow25.65
EV to Operating Cash Flow25.65
Balance Sheet
Medline has $2.24B in cash and marketable securities with $12.57B in debt, giving a net cash position of -$10.34B billion.
Cash & Marketable Securities$2.24B
Total Debt$12.57B
Net Cash-$10.34B
Net Cash Per Share-$12.22
Tangible Book Value Per Share-$3.31
Margins
Gross margin is 24.04%, with operating margin of 7.78%, and net profit margin of 4.08%.
Gross Margin24.04%
Operating Margin7.78%
Pretax Margin4.39%
Net Profit Margin4.08%
EBITDA Margin10.26%
EBIT Margin7.78%
Analyst Forecast
The average price target for Medline is $52.83, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$52.83
Price Target Upside10.90% Upside
Analyst ConsensusStrong Buy
Analyst Count24
Revenue Growth Forecast12.07%
EPS Growth Forecast-22.07%